A Cohort Study of Real-world Geriatric Comorbidities Patients Management based on PGx

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300075868

Enrollment

Unknown

Registered

2023-09-18

Start date

2023-02-01

Completion date

Unknown

Last updated

2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gerontology

Interventions

Intervention group :PGx testing: send the patient s peripheral blood samples to the precision laboratory of our hospital, and use Sequenom's high-precision nucleic acid analysis platform based on mass

Control group:Based on the main doctor‘s experience to formulate corresponding treatment plans.

Eligibility

Sex/Gender

All

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age =60 2. Clear consciousness 3. Signed informed consent form

Exclusion criteria

Exclusion criteria: 1. Severe cognitive dysfunction 2. Comorbid mental illness patient 3. Unable to cooperate with follow-up

Design outcomes

Primary

Measure	Time frame
Blood pressure;	—

Secondary

Measure	Time frame
Weight;Height;Waistline;	—

Countries

China

Contacts

Public ContactXiang Hong

People's Hospital of Xinjiang Urumqi Autonomous Region

zhc1969@sina.com+86 139 9942 5133

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026